CD274 and small cell lung carcinoma: Although chemotherapy using platinum and etoposide have been the standard regimens for SCLC for approximately 20–30 years, recent efforts to target the immune checkpoint inhibitor PD-(L)1 have changed the treatment paradigm in SCLC.